Charles River Laboratories (CRL) — Capital Reinvestment Ratio
Latest as of March 2026:
1.36x
Charles River Laboratories (CRL) has a Capital Reinvestment Ratio of 1.36x as of March 2026, meaning it reinvests 1% of its operating cash flow ($41.08 Million) in capital expenditures ($55.91 Million). See Charles River Laboratories (CRL) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.36x
Capex / Operating Cash Flow
Operating Cash Flow
$41.08 Million
USD
Capital Expenditures
$55.91 Million
USD
Data as of
Mar 2026
Most recent filing
Charles River Laboratories Capital Reinvestment Ratio (1998–2025)
This chart tracks Charles River Laboratories's Capital Reinvestment Ratio across 28 annual periods.
Annual Capital Reinvestment Ratio for Charles River Laboratories (1998–2025)
Year-by-year Capital Reinvestment Ratio for Charles River Laboratories from 1998 to 2025. For live market cap and broader valuation context, see market cap of Charles River Laboratories.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | $737.65 Million | $219.15 Million | ▼ -6.3% |
| 2024 | 0.32x | $734.58 Million | $232.97 Million | ▼ -31.9% |
| 2023 | 0.47x | $683.90 Million | $318.53 Million | ▼ -11.1% |
| 2022 | 0.52x | $619.64 Million | $324.73 Million | ▲ +74.3% |
| 2021 | 0.30x | $760.80 Million | $228.77 Million | ▼ -1.3% |
| 2020 | 0.30x | $546.58 Million | $166.56 Million | ▲ +4.3% |
| 2019 | 0.29x | $480.94 Million | $140.51 Million | ▼ -8.0% |
| 2018 | 0.32x | $441.14 Million | $140.05 Million | ▲ +21.8% |
| 2017 | 0.26x | $316.26 Million | $82.43 Million | ▲ +40.6% |
| 2016 | 0.19x | $298.32 Million | $55.29 Million | ▼ -16.1% |
| 2015 | 0.22x | $286.36 Million | $63.25 Million | ▼ -2.6% |
| 2014 | 0.23x | $251.05 Million | $56.92 Million | ▲ +20.0% |
| 2013 | 0.19x | $207.14 Million | $39.15 Million | ▼ -17.3% |
| 2012 | 0.23x | $207.90 Million | $47.53 Million | ▼ -4.5% |
| 2011 | 0.24x | $205.28 Million | $49.14 Million | ▼ -5.6% |
| 2010 | 0.25x | $169.01 Million | $42.86 Million | ▼ -28.7% |
| 2009 | 0.36x | $225.04 Million | $80.01 Million | ▼ -49.5% |
| 2008 | 0.70x | $279.95 Million | $197.08 Million | ▼ -11.9% |
| 2007 | 0.80x | $284.25 Million | $227.04 Million | ▼ -27.8% |
| 2006 | 1.11x | $164.37 Million | $181.75 Million | ▲ +173.9% |
| 2005 | 0.40x | $236.70 Million | $95.55 Million | ▲ +64.6% |
| 2004 | 0.25x | $184.83 Million | $45.34 Million | ▼ -7.2% |
| 2003 | 0.26x | $123.77 Million | $32.70 Million | ▼ -5.9% |
| 2002 | 0.28x | $133.66 Million | $37.54 Million | ▼ -45.4% |
| 2001 | 0.51x | $71.30 Million | $36.66 Million | ▲ +11.5% |
| 2000 | 0.46x | $33.77 Million | $15.56 Million | ▲ +33.7% |
| 1999 | 0.34x | $37.57 Million | $12.95 Million | ▲ +8.2% |
| 1998 | 0.32x | $37.38 Million | $11.91 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow